child |
LDLo |
oral |
10mg/kg/30D-I (10mg/kg) |
CARDIAC: CARDIOMYOPATHY INCLUDING INFARCTION |
British Journal of Clinical Practice. Vol. 44, Pg. 633, 1990.
|
dog |
LD50 |
intravenous |
4mg/kg (4mg/kg) |
|
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 948, 1967.
|
guinea pig |
LD50 |
intravenous |
6mg/kg (6mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 948, 1967.
|
hamster |
LDLo |
intravenous |
50mg/kg (50mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 15, Pg. 1614, 1973. |
human |
LDLo |
oral |
6mg/kg (6mg/kg) |
CARDIAC: OTHER CHANGES |
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 521, 1969. |
mouse |
LD50 |
intraperitoneal |
2500ug/kg (2.5mg/kg) |
GASTROINTESTINAL: OTHER CHANGES |
National Cancer Institute Report. Vol. -, Pg. 304, 1967. |
mouse |
LD50 |
intravenous |
8600ug/kg (8.6mg/kg) |
|
Cancer Research. Vol. 49, Pg. 4098, 1989.
|
mouse |
LD50 |
oral |
205mg/kg (205mg/kg) |
|
Yakkyoku. Pharmacy. Vol. 25, Pg. 573, 1974. |
mouse |
LD50 |
unreported |
24900ug/kg (24.9mg/kg) |
|
Biochemical Pharmacology. Vol. 38, Pg. 167, 1989.
|
rabbit |
LD50 |
intravenous |
5mg/kg (5mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 948, 1967.
|
rat |
LD50 |
intraperitoneal |
20mg/kg (20mg/kg) |
|
Advances in Teratology. Vol. 3, Pg. 181, 1968. |
rat |
LD50 |
intravenous |
13mg/kg (13mg/kg) |
BLOOD: OTHER CHANGES
SKIN AND APPENDAGES (SKIN): HAIR: OTHER |
National Cancer Institute Report. Vol. -, Pg. 304, 1967. |
rat |
LD50 |
oral |
336mg/kg (336mg/kg) |
|
Yakkyoku. Pharmacy. Vol. 25, Pg. 573, 1974. |
rat |
LD50 |
subcutaneous |
33200ug/kg (33.2mg/kg) |
|
Yakkyoku. Pharmacy. Vol. 25, Pg. 573, 1974. |